Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

India Proposal for Immediate Suspension

The Government of India has issued a draft notification, G.S.R. 956(E), proposing a significant amendment

CDSCO Renews Push for ONDLS Registration

On 27 October, CDSCO issued a circular directing State Drug Controllers to ensure that vendors

Medical Device Labels in India To Displa

The Ministry of Health and Family Welfare, Government of India has issued the Medical Devices

FDA issues Guidance on Container Closure

The USFDA has released a new draft guidance, Container Closure Systems for Human Drugs and

USFDA Issues Guidance for Impurity Speci

The USFDA has issued a draft guidance for Establishing Impurity Specifications for Antibiotics in April

Antibiotics to Carry Blue Strip Label in

The Government of India has published a draft notification proposing an amendment to the Drugs

Imprimis Recall Unapproved Ophthalmic In

Imprimis NJOF recalled three intraocular ophthalmic injection drug products in December 2025 (as per USFDA

USFDA Updates Consideration for CES for

Biosimilarity CAA more sensitive than CES The USFDA has published a draft guidance updating scientific

India to Allow Manufacture of New Drugs

Government of India is amending the New Drugs and Clinical Trials (NDCT) Rules 2019 permitting

India Makes Disclosure of Excipients on

Government of India has published the Gazette notification to make disclosure of Qualitative details of